P. Harris

发表

Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)

Tej D Azad, Tej D. Azad, Kevin Chen, 2019, Molecular Diagnosis & Therapy.

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

C. J. Dunn, I. Reardon, R. Heinrikson, 1990, Nature.

Crystallization of purified recombinant human interleukin‐1β

H. M. Einspahr, Donald B. Carter, K. D. Watenpaugh, 1988, Proteins.

Cell-free DNA alterations in the AR enhancer and locus predict resistance to AR-directed therapy in patients with metastatic prostate cancer.

Jingqin Luo, C. Maher, A. Chaudhuri, 2020, JCO precision oncology.

High-dimensional deconstruction of pancreatic ductal adenocarcinoma identifies tumor microenvironmental communities associated with survival

A. Chaudhuri, D. Early, V. Kushnir, 2022, medRxiv.

α‐Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c‐MET and MSP/RON Kinase Pathway Signaling in Cancer

L. Klampfer, S. Wildman, J. Janetka, 2016, ChemMedChem.

M. Yao, E. Cole, D. Chalker, 2016, Biology Open.

Identification of dioxin-responsive genes in Hep G2 cells using differential mRNA display RT-PCR.

R. Ulrich, R. Voorman, P. Harris, 1996, Biochemical and biophysical research communications.

Platelet-derived growth factor induces interleukin-1 receptor gene expression in Balb/c 3T3 fibroblasts.

W. Chiou, P. Harris, D. Carter, 1989, The Journal of biological chemistry.

Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.

S. Wildman, J. Janetka, P. Harris, 2015, Bioorganic & medicinal chemistry.

Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.

S. Rapp, M. D. Ennis, P. Harris, 2010, Journal of medicinal chemistry.

Adipocyte fatty acid-binding protein: regulation of gene expression in vivo and in vitro by an insulin-sensitizing agent.

S. Clarke, P. Harris, R. Kletzien, 1992, Molecular pharmacology.

Crystallization of recombinant human interleukin 1β

J. Paslay, S. Muchmore, I. Reardon, 1988 .

Part II: piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.

S. Rapp, M. D. Ennis, P. Harris, 2010, Bioorganic & medicinal chemistry letters.

T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma

Milad R. Vahid, Aaron M. Newman, Alexander X. Lozano, 2022, Nature Medicine.

Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study

Jimmy D Bell, A. Chaudhuri, A. Hirbe, 2021, PLoS medicine.

Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study

Jimmy D Bell, A. Chaudhuri, P. Jones, 2021, medRxiv.

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine

A. Chaudhuri, M. Mutch, R. Fields, 2021, JCO precision oncology.

Inhibitors of HGFA, Matriptase, and Hepsin Serine Proteases: A Nonkinase Strategy to Block Cell Signaling in Cancer.

S. Wildman, J. Janetka, W. Shen, 2014, ACS medicinal chemistry letters.

Effects of platelet-derived growth factor on phosphorylation of the epidermal growth factor receptor in human skin fibroblasts.

S. Decker, P. Harris, 1989, The Journal of biological chemistry.

Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist.

David C. Wood, K. Fennell, R. Kurumbail, 2018, Journal of medicinal chemistry.

Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors

A. Chaudhuri, P. Chauhan, J. Zevallos, 2021, Molecular Diagnosis & Therapy.

Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management.

A. Chaudhuri, V. Arora, P. Chauhan, 2020, JCO precision oncology.

Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study

A. Chaudhuri, V. Arora, P. Chauhan, 2021, PLoS medicine.

Isolation and sequence of a rat glucose-6-phosphate dehydrogenase promoter.

K. Rank, S. Stapleton, L. Ginsberg, 1994, Biochimica et biophysica acta.

Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)

A. Chaudhuri, J. Dudley, R. Chin, 2019, Molecular Diagnosis & Therapy.

Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients

A. Chaudhuri, P. Chauhan, B. Baumann, 2023, npj Precision Oncology.

Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non–Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules

Jonathan B. Mitchem, A. Chaudhuri, K. Pantel, 2022, JCO precision oncology.

Crystallization of purified recombinant human interleukin-1 beta.

J. Paslay, K. A. Curry, C. C. Tomich, 1988, Proteins.

Preservation of Proteins in Human Plasma through Metal-Organic Framework Encapsulation.

A. Chaudhuri, S. Singamaneni, J. Morrissey, 2023, ACS applied materials & interfaces.